The Novavax COVID-19 protein vaccine has been approved by the ATAGI as a booster alternative to mRNA vaccines for Australians aged 18 and over. The ATAGI stated (pdf) that the Novavax COVID-19 vaccine currently has “limited evidence” on its safety and immunogenicity as a booster, but is acceptable as a third shot if “no other COVID-19…

The decision to change the definition of fully vaccinated from two to three jabs could create confusion if Australian state governments decide to expand current booster mandates, according to vaccine developer Nikolai Petrovsky. On Feb. 10, the Australian Technical Advisory Group on Immunisation (ATAGI), announced that individuals would only be considered “fully vaccinated” or “up-to-date” if…

The Australian Technical Advisory Group on Immunisation (ATAGI) cannot rule out four or five doses for COVID-19 vaccines for Australians to be “up to date.” The chair for ATAGI, Nigel Crawford said that his organisation will continue to monitor data from other countries administering four doses at the senate hearing on Feb. 16. ATAGI announced…

The head of Australia’s technical advisory body to the health minister has not ruled out changing the definition of what constitutes being fully vaccinated or “up to date” to four or five jabs. The chair for the Australian Technical Advisory Group on Immunisation (ATAGI), Nigel Crawford said that his organisation will continue to monitor data from…

The ATAGI has updated its guidelines around COVID-19 vaccinations saying that Australians will need three COVID-19 vaccine doses to be considered fully vaccinated on Feb. 10. For Australians to be “up-to-date” on their COVID-19 vaccinations, it is now recommended that they have a booster shot within three months to 6 months from the primary course for…

The Australian Technical Advisory Group on Immunisation (ATAGI) have approved booster shots for teens aged 16 and above, effective Feb. 3. Teenagers will be receiving the same dosage as adults and the recommended booster interval period is also three months after the primary doses. Health Minister Greg Hunt welcomed the news saying it was good…

The national drug regulator has given the green light to the Novavax vaccine, along with two oral treatments for patients currently suffering from COVID-19. The Therapeutic Goods Administration (TGA) on Thursday approved the Novavax vaccine, also called Nuvaxovid, for adults aged 18 years and over, making it the first protein-based COVID-19 vaccine in the country’s…